Jump Financial’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Jump Financial’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$257K	Buy	+2,553	New	+$215K	﹤0.01%	1741
2023 Q4	–	Sell	-8,190	Closed	-$393K	–	1796
2023 Q3	$393K	Sell	8,190 -7,627	-48%	-$392K	0.01%	1143
2023 Q2	$823K	Buy	15,817 +4,249	+37%	+$234K	0.03%	790
2023 Q1	$627K	Buy	+11,568	New	+$653K	0.03%	789
2022 Q2	–	Sell	-8,301	Closed	-$515K	–	1623
2022 Q1	$515K	Buy	+8,301	New	+$510K	0.02%	798

Other funds holding BIB

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

KFS

Kaizen Financial Strategies Campbell, California $308M AUM 41.73% 1-Year Est. Return

PWM

Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $474M AUM 95.11% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

ATPW

Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Jump Financial's BIB Position: Q2 2026 in Review

Jump Financial opened a new position in ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2026: 2,553 shares worth $257K. The stake represents ﹤0.01% of the portfolio and ranks #1741 among its holdings. This is a return to the name: Jump Financial previously reported a position in BIB as recently as Q3 2023.

Jump Financial first reported a position in BIB in Q1 2022 and has held it in 5 quarters since. The position peaked at $823K in Q2 2023. 20 funds tracked by Wall St. Rank hold BIB as of Q2 2026.

Jump Financial held 2,553 shares of ProShares Ultra NASDAQ Biotechnology worth $257K as of Q2 2026.
ProShares Ultra NASDAQ Biotechnology was a new Jump Financial position in Q2 2026.
ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1741 holding.
Jump Financial first reported a position in ProShares Ultra NASDAQ Biotechnology in Q1 2022 and has held it in 5 quarters since.
Jump Financial's ProShares Ultra NASDAQ Biotechnology position peaked at $823K in Q2 2023.
20 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.